We are experiencing a revolution in cancer. Advances in screening, targeted and immune
therapies, big data, computational methodologies, and significant new knowledge of cancer …

A MESSAGE FROM ASCO'S PRESIDENT I remember when ASCO first conceived of
publishing an annual report on the most transformative research occurring in cancer care …

A MESSAGE FROM ASCO'S PRESIDENT I am pleased to present Clinical Cancer
Advances 2017, which highlights the most promising advances in patient-oriented cancer …

The last ten years have seen remarkable progress in cancer research. However, despite
significant breakthroughs in the understanding, prevention, and treatment of cancer, the …

Cancer therapeutics currently have the lowest clinical trial success rate of all major
diseases. Partly as a result of the paucity of successful anti-cancer drugs, cancer will soon …

The coalescence of new scientific insights and technological innovations has improved our
prospects for success against cancer. The cancer “moonshot” aims to increase the …

A MESSAGE FROM ASCO'S PRESIDENT It has been forty years since President Richard
Nixon signed the National Cancer Act of 1971, which many view as the nation's declaration …

Each year Clinical Cancer Advances: ASCO's Annual Report on Progress Against Cancer
highlights the most important clinical research advances of the past year, including the …

EXECUTIVE SUMMARY In 2015, approximately 1.7 million Americans received a cancer
diagnosis. 1 In 2030, this number will rise to nearly 2.3 million. 2 Today, approximately two …

Research into cancer over the past 10 years has diverged enormously, partly based on the
large number of new technologies that are now at our finger tips. With areas of cancer …